Are hypoechoic lesions on transrectal ultrasonography a marker for clinically significant prostate cancer?
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Noh, T.I. | - |
dc.contributor.author | Shin, Y.S. | - |
dc.contributor.author | Shim, J.S. | - |
dc.contributor.author | Yoon, J.H. | - |
dc.contributor.author | Kim, J.H. | - |
dc.contributor.author | Bae, J.H. | - |
dc.contributor.author | Moon, D.G. | - |
dc.contributor.author | Park, J.Y. | - |
dc.date.accessioned | 2021-09-06T09:41:32Z | - |
dc.date.available | 2021-09-06T09:41:32Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 2005-6737 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/105865 | - |
dc.description.abstract | Purpose: To investigate the relationship of transrectal ultrasound (TRUS) findings with the pathological characteristics of prostate cancer (PCa). Materials andMethods: The study was conducted retrospectively by analyzing the data for 970 patients who underwent prostate biopsies. Gleason scores and other clinical variables were compared between PCa patients with and without hypoechoic lesions on TRUS. Results: Of the 970 patients, PCa was diagnosed in 291 (30%). Of these, high-grade PCa (Gleason score of 7 or more) was diagnosed in 190 (65%). The cancer detection rate was higher in patients with hypoechoic lesions (43.9%) than in those without hypoechoic lesions (21.4%, p<0.001). High-grade PCa was detected more often in patients with hypoechoic lesions than in those without hypoechoic lesions (p<0.001). Independent predictors for high-grade PCa by logistic regression analysis included hypoechoic le-sions on TRUS and abnormal digital rectal examination findings. Conclusions: Patients with PCa who had hypoechoic lesions on TRUS had more ag-gressive pathological disease than did those without lesions. Therefore, hypoechoic le-sions on TRUS could be a marker for clinically significant PCa. © The Korean Urological Association, 2013. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.subject | prostate specific antigen | - |
dc.subject | adult | - |
dc.subject | age | - |
dc.subject | aged | - |
dc.subject | article | - |
dc.subject | biopsy needle | - |
dc.subject | digital rectal examination | - |
dc.subject | disease marker | - |
dc.subject | Gleason score | - |
dc.subject | human | - |
dc.subject | human tissue | - |
dc.subject | logistic regression analysis | - |
dc.subject | major clinical study | - |
dc.subject | male | - |
dc.subject | predictive value | - |
dc.subject | prostate biopsy | - |
dc.subject | prostate cancer | - |
dc.subject | prostate lesion monitor | - |
dc.subject | prostate volume | - |
dc.subject | retrospective study | - |
dc.subject | transrectal ultrasonography | - |
dc.title | Are hypoechoic lesions on transrectal ultrasonography a marker for clinically significant prostate cancer? | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Bae, J.H. | - |
dc.contributor.affiliatedAuthor | Moon, D.G. | - |
dc.contributor.affiliatedAuthor | Park, J.Y. | - |
dc.identifier.doi | 10.4111/kju.2013.54.10.666 | - |
dc.identifier.scopusid | 2-s2.0-84886280487 | - |
dc.identifier.bibliographicCitation | Korean Journal of Urology, v.54, no.10, pp.666 - 670 | - |
dc.relation.isPartOf | Korean Journal of Urology | - |
dc.citation.title | Korean Journal of Urology | - |
dc.citation.volume | 54 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 666 | - |
dc.citation.endPage | 670 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001812683 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | prostate specific antigen | - |
dc.subject.keywordPlus | adult | - |
dc.subject.keywordPlus | age | - |
dc.subject.keywordPlus | aged | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | biopsy needle | - |
dc.subject.keywordPlus | digital rectal examination | - |
dc.subject.keywordPlus | disease marker | - |
dc.subject.keywordPlus | Gleason score | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | human tissue | - |
dc.subject.keywordPlus | logistic regression analysis | - |
dc.subject.keywordPlus | major clinical study | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | predictive value | - |
dc.subject.keywordPlus | prostate biopsy | - |
dc.subject.keywordPlus | prostate cancer | - |
dc.subject.keywordPlus | prostate lesion monitor | - |
dc.subject.keywordPlus | prostate volume | - |
dc.subject.keywordPlus | retrospective study | - |
dc.subject.keywordPlus | transrectal ultrasonography | - |
dc.subject.keywordAuthor | Clinical marker | - |
dc.subject.keywordAuthor | Prostate neoplasms | - |
dc.subject.keywordAuthor | Ultrasonography | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.